SALIM VIRANI to Rivaroxaban
This is a "connection" page, showing publications SALIM VIRANI has written about Rivaroxaban.
Connection Strength
0.876
-
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.
Score: 0.694
-
Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry. Am Heart J. 2021 10; 240:58-62.
Score: 0.182